• 대한산업공학회지
• /
• 제25권4호
• /
• pp.448-458
• /
• 1999

This paper proposes sequential control charts with an upper bound on sample size. Existing sequential control charts have no restriction on the number of observations at a sampling point. For situations where sampling and testing an item is time-consuming or expensive, sequential control charts may not be directly applied. When the number of observations in a sampling point reaches the upper bound and there is no out-of-control signal, the proposed cumulative sequential control chart defers the decision to the next sampling point of which starting value is the value of the current statistic. Two Markov chains, inner and outer chains, are used to derive the formulas for evaluating the performance of the proposed chart. It is compared with $\bar{X}$ and cumulative sum control charts with fixed and variable sample sizes. The fast initial response (FIR) feature is studied. Guidelines for the design of the proposed charts are also given.

• 한국지능정보시스템학회:학술대회논문집
• /
• 한국지능정보시스템학회 2003년도 춘계학술대회
• /
• pp.366-376
• /
• 2003

Recently, market size for IT outsourcing has grown. As internet technology has been developed for accessing information resources, information systems have become internet-based, which is called an ASP(Application Service Provider); evaluating the performance fur ASP becomes important. Therefore, this paper attempts to investigate the salient characteristics of ASP An ASP success model is proposed based on information systems success models found in the literature. Our model is tested through a survey from 291 small companies. LISREL is used to demonstrate the suitability of our model, and the success factors for ASP are also investigated. Our result is likely to help provide useful guidelines for successful ASP implementation.

• 산업경영시스템학회지
• /
• 제36권1호
• /
• pp.44-52
• /
• 2013

For evaluating participation in collaboration project, the peer assement method is mostly used and various scoring methods have been proposed. But, the reliability and validity of the peer assessment method are still doubted for all most method. In order to overcome these weaknesss, some guidelines and training methods have been recommended. In this article, however, statistical technique is proposed for measuring individual contributions to collaboration projects considering each assessor's reliability. The gist of our proposed algorithm is that an assessor's reliability depends on the evaluation policy, and this reliability is evaluated by an analysis of variance of the scores assigned by the assessor. We also show that the proposed method is very efficient by case study in university class.

• 한국건축시공학회:학술대회논문집
• /
• 한국건축시공학회 2023년도 가을학술발표대회논문집
• /
• pp.277-278
• /
• 2023

In 2022, construction had a five fold higher accident and fatality rate compared to the overall industry. The Construction Technology Promotion Act requires parties in construction contracts to calculate safety costs following Ministry of Land, Infrastructure and Transport guidelines. Understanding safety expense components is vital for evaluating accident prevention costs and planning anti-accident strategies. A study surveyed safety professionals to analyze the importance and influence of safety management expense components, providing basic data for future research. Survey results highlighted the significance of safety management plans, structural safety assurance, and preventing collateral damage.

• 대한의용생체공학회:의공학회지
• /
• 제40권5호
• /
• pp.197-205
• /
• 2019

The existing Extracorporeal membrane oxygenation(ECMO) and Cardiopulmonary bypass system(CPB) have been developed and applied to various devices according to their respective indications. However, due to the complicated configuration and difficult usage method, it causes inconvenience to users and there is a risk of an accident. Therefore, smart all-in-one cardiopulmonary circulation device is being developed recently. The smart all-in-one cardiopulmonary assist device consists of a blood pump for cardiopulmonary bypass, a blood oxidizer for cardiopulmonary bypass, a blood circuit for cardiopulmonary bypass, and an artificial cardiopulmonary device. It is an integrated cardiopulmonary bypass device that can be used for a variety of purposes such as emergency, intraoperative, post-operative intensive care, and long-term cardiopulmonary assist, combined with CPB used in open heart surgery and ECMO used when patient's cardiopulmonary function does not work normally. The smart all-in-one cardiopulmonary assist device does not exist as a standard and international standard applicable to advanced medical devices. Therefore, in this study, we will refer to the International Standard for Blood Components, the International Standard for Blood, the Guideline for Blood Products, and prepare applicable performance and safety guidelines to help quality control of medical devices, and contribute to the improvement of the health of people. The guideline, which is the result of conducted a survey of the method of safety and performance test, is based on the principle of all-in-one cardiopulmonary aiding device, related domestic foreign standards, the status of domestic and foreign patents, related literature, blood pump(ISO 18242), blood oxygenator (ISO 7199), and blood circuit (ISO 15676) for cardiopulmonary bypass.The items on blood safety are as follows: American Society for Testing and Materials ASTM F1841-97R17), and in the 2010 Food and Drug Administration's Safety Assessment Guidelines for Medical Assisted Circulatory Devices. In addition, after reviewing the guidelines drawn up through expert consultation bodies including manufacturers / importers, testing inspectors, academia, etc. the final guideline was established through revision and supplementation process. Therefore, we propose guidelines for evaluating the safety and performance of smart all-in-one cardiopulmonary assist devices in line with growing technology.

• 대한의용생체공학회:의공학회지
• /
• 제40권5호
• /
• pp.215-221
• /
• 2019

The respiratory medical device is a medical device that delivers optimal oxygen or a certain amount of humidification to a patient by delivering artificial respiration to a patient through a machine when the patient has lost the ability to breathe spontaneously. These include respirators for use in chronic obstructive pulmonary disease and anesthesia or emergency situations, and positive airway pressure devices for treating sleep apnea, and as the population of COPD (chronic obstructive pulmonary disease) and elderly people worldwide surge, the market for the respiratory medical devices it is getting bigger. As the demand for both airway pressure devices, there is a problem that the ventilator standard is applied because the reference standard has not been established. Therefore, the boundaries between the items are blurred due to the purpose, intended use, and method of use overlapping similar items in a respiratory medical device. In addition, for both airway pressure devices, there is a problem that the ventilator standard is applied because the reference standard has not been established. Therefore, in this study, we propose clear classification criteria for the respiratory medical devices according to the purpose, intended use, and method of use and provide safety and performance evaluation guidelines for those items to help quality control of the medical devices. And to contribute to the rapid regulating and improvement of public health. This study investigated the safety and performance test methods through the principles of the respiratory medical device, national and international standards, domestic and international licensing status, and related literature surveys. The results of this study are derived from the safety and performance test items in the individual ventilator(ISO 80601-2-72), the International Standard for positive airway pressure device (ISO 80601-2-70), The safety and performance of humidifiers (ISO 80601-2-74) and the safety evaluation items related to home healthcare environment (IEC 60601-1-11), In addition, after reviewing the guidelines drawn up through expert consultation bodies including manufacturers and importers, certified test inspection institutions, academia, etc., the final guidelines were established through revision and supplementation. Therefore, in this study, we propose guidelines for evaluating the safety and performance of the respiratory medical device in accordance with growing technology development.

• 대한예방한의학회지
• /
• 제19권3호
• /
• pp.115-129
• /
• 2015

Objective : This study aims to review clinical studies evaluating effectiveness of Korean medicine for smoking cessation. It also aims to critically analyze study design of the studies and suggest strategies for future clinical studies on smoking cessation. Method : Only domestic databases such as RISS, KISS, DBPIA, NDSL, and OASIS were searched from August to November 2011 for clinical studies on smoking cessation. There was no limitation on study design, period, and language. The studies were qualitatively analyzed focusing on study design including participants, intervention, and outcome measurements. Results : Out of 537 studies searched, 27 studies were included in the analysis. 56% of the studies were observational studies, 33% were quasi-experimental studies, and 11% were randomized controlled studies. 44% and 32% of the studies were conducted at educational institutions and hospitals, respectively. The average number of the participants were 182, which ranged from 15 to 1,056. Most of the participants were male. Intervention used were mostly auricular acupuncture, and the most frequently used acupoints were Lung, Shinmun, Endocrine, Pharynx & Larynx, and Inner nose. The average length of treatment period was four weeks, and the treatment was provided twice per week. The outcomes were measured at the end of the treatment and only 26% of the studies conducted follow-up measurements. 26% of the studies utilized questionnaires of which validity was evaluated and only 15% used objective measurements such as exhaled Carbon monoxide and Cotinine test. Conclusion : Though many clinical studies on effectiveness of Korean medicine for smoking cessation were conducted, there are still debates on quality of evidence. Recently, guidelines have been developed for clinical trials evaluating effectiveness of smoking cessation program. Thus, in the future, clinical studies should be developed based on these guidelines and designed to improve validity and reliability.

• 한국산학기술학회논문지
• /
• 제15권1호
• /
• pp.331-343
• /
• 2014

본 연구의 목적은 National Collaborating Centre for Nursing and Supportive Care (NCC-NSC)에서 개발한 수술 환자의 체온 관리 근거중심 가이드라인의 국내 타당성을 검증하기 위한 것이다. 수술 환자 관리 경험 및 지식이 풍부한 의사와 간호사 총 180명으로 구성된 전문가 집단을 대상으로 가이드라인 각각의 권고사항에 대한 적절성과 적용가능성을 평가하였다. 수집한 자료는 SPSS/WIN 18.0을 이용하여 평균, 표준편차, paired t-test 이용하여 분석하였다. 가이드라인의 적절성과 적용가능성은 9점 척도로 각각 평균 8.11점과 7.28점으로 높게 나타났으며, 대부분의 권고사항의 적절성과 적용가능성도 평균 6-8점 이상으로 비교적 높게 평가되었다. 그러나 대부분의 가이드라인 권고사항에서 적절성이 적용가능성 보다 유의하게 높게 나타나, 실제 임상환경에서 가이드라인의 권고사항을 직접 적용하는 데는 장애가 있는 것으로 나타났다. 따라서 가이드라인의 권고사항을 임상환경에 적용하는 데 장애가 되는 요인을 확인하고 이를 적절히 해결하는 방안이 모색되어야 할 것이다.

• 한국콘텐츠학회논문지
• /
• 제20권9호
• /
• pp.439-447
• /
• 2020

공공데이터는 공공기관이 전자적으로 생성 또는 취득하여 관리하고 있는 모든 정보와 전자화된 파일이다. 공공데이터는 인공지능, 스마트 시티 등 차세대 신산업을 견인하는 중요한 요소로 인식되고 있다. 한국은 공공데이터 개방과 관련된 국제 평가에서 연속적으로 높은 순위에 위치하고 있다. 그럼에도 불구하고 공공데이터의 활용과 산업적 영향은 미흡하다. 공공데이터의 활용이 미흡한 이유는 다양할 수 있지만, 데이터 품질은 지속적으로 논의되는 주요 이슈이다. 본 논문은 공공데이터 품질 평가를 위한 지표를 검토하고, 개방된 공공데이터를 대상으로 정량적 품질 평가를 수행한다. 특히, 공공데이터 관리지침을 기준으로 구축 및 개방된 개방표준 데이터의 품질을 진단하여 정부의 가이드라인이 적합한지 검토한다. 데이터 품질평가는 개방표준 데이터의 메타데이터와 데이터값을 포함하고, 완전성과 정확성 지표를 기준으로 검토한다. 데이터 분석결과를 바탕으로 품질 개선을 위한 정책적·기술적 방안을 제안한다.

• 간호행정학회지
• /
• 제19권1호
• /
• pp.87-94
• /
• 2013

Purpose: The purpose of this study was to provide a basis for non-humidified low flow oxygen by nasal cannula and to provide a guide for consistent care in nursing practice. Methods: A methodological study on the development of guidelines with experts' opinions on collected items, framing PICO questions, evaluating and synthesizing texts which were searched with the key words (low flow oxygen, nasal cannula, humidification of oxygen, guideline) from web search engines. Results: Of the 45 researched texts on the web, 9 texts relevant to the theme were synthesized and evaluated. All patients with humidified or non-humidified oxygen therapy reported that they had no discomfort. Conclusion: The results indicate that there are no tangible grounds for patients' perceived differences between the humidified and non-humidified oxygen under 4L/min supplied by nasal cannula. with oxygen. Therefore, non-humidification oxygen therapy is strongly advised when suppling under 4L/min oxygen by nasal cannula (recommended grade A).